Created in 2007 (Belgium), LEVEPRIL own 359 sister brands and 2214 competing brands. The LEVEPRIL brand is owned by UCB, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0003739530. LEVEPRIL belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
UCB
(LEVEPRIL)
over 5 years*
EUR 223.78